MedTrace Logo

Tobacco Treatment for Employable Californians, Total IMPACT Study

NCT02478697 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 360

Last updated 2024-03-20

No results posted yet for this study

Summary

Previous findings indicate elevated risk for tobacco use among adults in California who are unemployed and seeking work. In a pilot study, tobacco use was associated with a longer duration of time out of work. This community-based participatory research study aims to deliver and evaluate the impact of a web-based job seeker tailored tobacco cessation intervention vs. a control group in the San Francisco Bay Area. This research investigates whether an employment-centered tobacco treatment intervention is efficacious in supporting abstinence and also associated with more timely engagement of employment.

Conditions

  • Tobacco Dependence

Interventions

BEHAVIORAL

ProChange ExpertSystem

The computer program assesses stage of change and TTM constructs of temptations, decisional balance, and processes of change. Repeat intervention contacts occur at baseline, 3- and 6-months follow-up, providing iterative computerized feedback reflecting prior responses with encouragement for quitting smoking and relapse prevention.

Sponsors & Collaborators

  • San Francisco Employment Development Department

    collaborator UNKNOWN

  • CareerPoint Marin

    collaborator OTHER

  • JobTrain

    collaborator UNKNOWN

  • Marin City Community Development Corporation

    collaborator UNKNOWN

  • Oakland Employment Development Department

    collaborator UNKNOWN

  • Stanford University

    lead OTHER

Principal Investigators

  • Judith J Prochaska, PhD, MPH · Stanford University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2018-09-12
Completion
2018-09-12

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02478697 on ClinicalTrials.gov